UNITED KINGDOM—Portable oxygen concentrator (POC) maker Belluscura announced that it has begun a strategic review with the goal of generating new capital.

The company said that the U.S. import tariff on its portable oxygen containers remains at zero, pending any new changes. The company said this tariff number continues to support Belluscura's cost structure and reinforces its ability to offer competitively priced products.

HME organization joined Advamed & others in letter to U.S. Trade Representative Jameison Greer over global tariffs

WASHINGTON—The American Association for Homecare (AAHomecare) has joined a group of organizations urging an exemption from tariffs for medical and dental supplies, equipment and devices, citing concerns about increased costs resulting in supply chain disruptions.

AAHomecare emphasized the impact tariffs would have on DMEs & the people they serve

ARLINGTON, Virginia—In early March, the Trump Administration delayed proposed 25% tariff increases on products covered under the 2020 United States-Mexico-Canada Agreement (USMCA) until April. These potential new tariffs would join 20% tariffs on products from China already in effect.


WASHINGTON, D.C. (June 20, 2018)—On Friday, June 16, 2018, the Administration announced that Section 301 Tariffs on a range of products imported from China would move forward. Thanks in part to quick action by DME stakeholders, several product categories were among items removed from the original 1,333 items proposed for a 25 percent tariff levy.